AI Engines For more Details: Perplexity Kagi Labs You
Absence Seizures:
Epilepsy:
Other Seizure Disorders:
Adverse Effects:
Blood Monitoring:
Precautions:
Dosage Adjustment:
Rank | Probiotic | Impact |
---|---|---|
genus | Bifidobacterium | Reduces |
species | Akkermansia muciniphila | Reduces |
species | Bifidobacterium adolescentis | Reduces |
species | Bifidobacterium longum | Reduces |
species | Escherichia coli | Reduces |
subspecies | Bifidobacterium longum subsp. infantis | Reduces |
subspecies | Bifidobacterium longum subsp. longum | Reduces |
We extend modifiers to include items that changes the parent and child taxa. I.e. for a species, that would be the genus that is belongs to and the strains in the species.
A higher number indicates impact on more bacteria associated with the condition and confidence on the impact.
We have X bacteria high and Y low reported. We find that the modifier reduces some and increases other of these two groups. We just tally: X|reduces + Y|Increase = Positive X|increases + Y|decrease = Negative.
Benefit Ratio:
Numbers above 0 have increasing positive effect.
Numbers below 0 have increasing negative effect.
Condition | Positive Impact | Negative Impact | Benefit Ratio Impact |
---|---|---|---|
Abdominal Aortic Aneurysm | 0.4 | 0.4 | |
Acne | 0.3 | 0.4 | -0.33 |
ADHD | 3.8 | 0.6 | 5.33 |
Age-Related Macular Degeneration and Glaucoma | 1.1 | 1.1 | |
Allergic Rhinitis (Hay Fever) | 2.5 | 2.6 | -0.04 |
Allergies | 6 | 3.6 | 0.67 |
Allergy to milk products | 2.2 | 1.2 | 0.83 |
Alopecia (Hair Loss) | 1 | 1 | |
Alzheimer's disease | 4.9 | 4.7 | 0.04 |
Amyotrophic lateral sclerosis (ALS) Motor Neuron | 3.2 | 1.4 | 1.29 |
Ankylosing spondylitis | 3.8 | 1 | 2.8 |
Anorexia Nervosa | 1.2 | 2.3 | -0.92 |
Antiphospholipid syndrome (APS) | 1 | 0.3 | 2.33 |
Asthma | 4.7 | 3.3 | 0.42 |
Atherosclerosis | 1.6 | 1.7 | -0.06 |
Atrial fibrillation | 2.5 | 1.5 | 0.67 |
Autism | 7.4 | 7.4 | 0 |
Autoimmune Disease | 1.2 | 1 | 0.2 |
Barrett esophagus cancer | 0.3 | 0.3 | 0 |
benign prostatic hyperplasia | 0.6 | 0.3 | 1 |
Biofilm | 1.2 | 1.2 | |
Bipolar Disorder | 2 | 1.4 | 0.43 |
Brain Trauma | 0.9 | 1.4 | -0.56 |
Breast Cancer | 0.4 | 0.4 | |
Cancer (General) | 0.6 | 1.8 | -2 |
Carcinoma | 3.6 | 2.2 | 0.64 |
Celiac Disease | 1.7 | 3.7 | -1.18 |
Cerebral Palsy | 1.7 | 1.3 | 0.31 |
Chronic Fatigue Syndrome | 4.8 | 4 | 0.2 |
Chronic Kidney Disease | 3.3 | 1.9 | 0.74 |
Chronic Lyme | 0.6 | 0.8 | -0.33 |
Chronic Obstructive Pulmonary Disease (COPD) | 1.1 | 1.4 | -0.27 |
Chronic Urticaria (Hives) | 1.8 | 0.7 | 1.57 |
Coagulation / Micro clot triggering bacteria | 1.3 | 1.3 | 0 |
Cognitive Function | 3.2 | 1.6 | 1 |
Colorectal Cancer | 5.1 | 2 | 1.55 |
Constipation | 1.5 | 0.7 | 1.14 |
Coronary artery disease | 2 | 1.5 | 0.33 |
COVID-19 | 8.2 | 8.6 | -0.05 |
Crohn's Disease | 5.6 | 4.5 | 0.24 |
Cushing's Syndrome (hypercortisolism) | 0.3 | -0.3 | |
cystic fibrosis | 1 | 1.9 | -0.9 |
d-lactic acidosis (one form of brain fog) | 0.4 | 0.4 | |
deep vein thrombosis | 2.3 | 1.4 | 0.64 |
Denture Wearers Oral Shifts | 1 | 1 | |
Depression | 8.4 | 7.6 | 0.11 |
Dermatomyositis | 0.3 | 0.3 | 0 |
Eczema | 1.5 | 1.5 | 0 |
Endometriosis | 2.6 | 2.1 | 0.24 |
Eosinophilic Esophagitis | 0.6 | -0.6 | |
Epilepsy | 2.7 | 1.7 | 0.59 |
erectile dysfunction | 1.2 | 0.3 | 3 |
Fibromyalgia | 2 | 0.8 | 1.5 |
Functional constipation / chronic idiopathic constipation | 4.3 | 2 | 1.15 |
gallstone disease (gsd) | 2.7 | 1.2 | 1.25 |
Gastroesophageal reflux disease (Gerd) including Barrett's esophagus | 0.3 | 1.2 | -3 |
Generalized anxiety disorder | 2.5 | 2.6 | -0.04 |
giant cell arteritis | 0.2 | -0.2 | |
Glioblastoma | 0.3 | -0.3 | |
Gout | 1.9 | 0.8 | 1.37 |
Graves' disease | 1.5 | 3 | -1 |
Gulf War Syndrome | 0.6 | 1.4 | -1.33 |
Halitosis | 0.9 | 0.3 | 2 |
Hashimoto's thyroiditis | 2.9 | 1.6 | 0.81 |
Heart Failure | 3.3 | 1.6 | 1.06 |
hemorrhagic stroke | 0.6 | 0.6 | |
Hidradenitis Suppurativa | 1.2 | 0.3 | 3 |
High Histamine/low DAO | 1.3 | 0.6 | 1.17 |
hypercholesterolemia (High Cholesterol) | 0.9 | 0.7 | 0.29 |
hyperglycemia | 2.3 | 1.7 | 0.35 |
Hyperlipidemia (High Blood Fats) | 1.2 | 0.3 | 3 |
hypersomnia | 0.7 | -0.7 | |
hypertension (High Blood Pressure | 4.2 | 5.1 | -0.21 |
Hypothyroidism | 0.3 | 0.7 | -1.33 |
Hypoxia | 2.8 | 0.3 | 8.33 |
IgA nephropathy (IgAN) | 1.2 | 3.2 | -1.67 |
Inflammatory Bowel Disease | 6 | 7.7 | -0.28 |
Insomnia | 1.7 | 3.2 | -0.88 |
Intelligence | 0.9 | 0.9 | |
Intracranial aneurysms | 0.7 | 0.6 | 0.17 |
Irritable Bowel Syndrome | 6.7 | 4.4 | 0.52 |
ischemic stroke | 2.9 | 1.4 | 1.07 |
Liver Cirrhosis | 6.4 | 5.1 | 0.25 |
Long COVID | 4.4 | 7.2 | -0.64 |
Low bone mineral density | 0.8 | -0.8 | |
Lung Cancer | 1 | 1.7 | -0.7 |
Lymphoma | 0.6 | 0.6 | |
Mast Cell Issues / mastitis | 0.9 | 0.6 | 0.5 |
ME/CFS with IBS | 1.1 | 1.8 | -0.64 |
ME/CFS without IBS | 1.4 | 1.8 | -0.29 |
membranous nephropathy | 0.3 | 0.3 | |
Menopause | 2.1 | 0.9 | 1.33 |
Metabolic Syndrome | 6.2 | 6.7 | -0.08 |
Mood Disorders | 8.8 | 6 | 0.47 |
multiple chemical sensitivity [MCS] | 1 | 0.1 | 9 |
Multiple Sclerosis | 5.9 | 3.2 | 0.84 |
Multiple system atrophy (MSA) | 1.7 | 0.7 | 1.43 |
myasthenia gravis | 0.9 | 0.7 | 0.29 |
neuropathic pain | 0.3 | 2.9 | -8.67 |
Neuropathy (all types) | 1 | 2.2 | -1.2 |
neuropsychiatric disorders (PANDAS, PANS) | 1 | 1 | |
Nonalcoholic Fatty Liver Disease (nafld) Nonalcoholic | 4.8 | 5 | -0.04 |
NonCeliac Gluten Sensitivity | 2 | 0.6 | 2.33 |
Obesity | 9.5 | 6.7 | 0.42 |
obsessive-compulsive disorder | 4.6 | 2.8 | 0.64 |
Osteoarthritis | 1.7 | 1.5 | 0.13 |
Osteoporosis | 2.5 | 2 | 0.25 |
pancreatic cancer | 0.6 | 0.3 | 1 |
Parkinson's Disease | 8 | 4.1 | 0.95 |
Polycystic ovary syndrome | 4 | 3.6 | 0.11 |
Postural orthostatic tachycardia syndrome | 0.2 | 0.3 | -0.5 |
Premenstrual dysphoric disorder | 0.7 | 0.7 | |
primary biliary cholangitis | 1.2 | 0.8 | 0.5 |
Primary sclerosing cholangitis | 1.7 | 1.4 | 0.21 |
Psoriasis | 3.5 | 1.5 | 1.33 |
rheumatoid arthritis (RA),Spondyloarthritis (SpA) | 7.1 | 2.9 | 1.45 |
Rosacea | 0.7 | 1 | -0.43 |
Schizophrenia | 5.8 | 2.7 | 1.15 |
scoliosis | 0.4 | 1 | -1.5 |
Sjögren syndrome | 2.2 | 1.9 | 0.16 |
Sleep Apnea | 1.6 | 1.6 | 0 |
Slow gastric motility / Gastroparesis | 1.3 | 0.3 | 3.33 |
Small Intestinal Bacterial Overgrowth (SIBO) | 1.5 | 0.6 | 1.5 |
Stress / posttraumatic stress disorder | 2.7 | 2.5 | 0.08 |
Systemic Lupus Erythematosus | 2.8 | 2 | 0.4 |
Tic Disorder | 0.9 | 1.2 | -0.33 |
Tourette syndrome | 1.2 | 0.3 | 3 |
Type 1 Diabetes | 3.7 | 3.8 | -0.03 |
Type 2 Diabetes | 6.4 | 6 | 0.07 |
Ulcerative colitis | 3.5 | 5.2 | -0.49 |
Unhealthy Ageing | 3.4 | 1.5 | 1.27 |
Vitiligo | 1.5 | 0.8 | 0.88 |